You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triple negative breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Looking At Triple Negative Breast Cancer Patient Experience

Not yet recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
    • (no location specified)
    Mar 3, 2023

    Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Proleukin 1.3 MG Injection
    • (no location specified)
    Apr 6, 2023

    Immunotherapy-related CRP Kinetics in Early and Metastatic

    Recruiting
    • TNBC - Triple-Negative Breast Cancer
      • Tuebingen, Germany
        Department of Women's Health
      Jun 13, 2023

      Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (proton plus carbon ion radiotherapy)

      Recruiting
      • Triple Negative Breast Cancer
      • HER2-positive Breast Cancer
      • proton plus carbon ion radiotherapy
      • Shanghai, China
        Shanghai Proton and Heavy Ion center
      Jan 11, 2023

      Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

      Recruiting
      • Triple Negative Breast Cancer
      • +3 more
      • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jun 15, 2023

      Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)

      Not yet recruiting
      • Breast Cancer
      • Triple Negative Breast Cancer
      • Imatinib 400 MG Oral Tablet
      • Gothenburg, Sweden
        Barbro Linderholm
      Feb 1, 2023

      Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Dhaka, Bangladesh
        Bangabandhu Sheikh Mujib Medical University
      May 24, 2023

      Advanced Triple Negative Breast Cancer Trial in Shantou (SZ011 CAR-NK)

      Not yet recruiting
      • Advanced Triple Negative Breast Cancer
      • SZ011 CAR-NK
      • Shantou, China
        Shantou
      Jan 9, 2023

      Metastatic Triple-negative Breast Cancer, Locally Advanced Triple-negative Breast Cancer Trial in Changsha, Xiangyang (AK117,

      Recruiting
      • Metastatic Triple-negative Breast Cancer
      • Locally Advanced Triple-negative Breast Cancer
      • Changsha, China
      • +1 more
      Sep 8, 2022

      Breast Cancer Female, Triple Negative Breast Cancer Trial (quercetin, EGCG, metformin , zinc)

      Not yet recruiting
      • Breast Cancer Female
      • Triple Negative Breast Cancer
      • quercetin, EGCG, metformin , zinc
      • (no location specified)
      Dec 23, 2022

      Triple Negative Breast Cancer Trial in Guangzhou (Chidamide combined with Zimberelimab)

      Recruiting
      • Triple Negative Breast Cancer
      • Chidamide combined with Zimberelimab
      • Guangzhou, Guangdong, China
        Sun Yat-sen University, Cancer Center
      Nov 20, 2022

      Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

      Not yet recruiting
      • Metastatic Triple-Negative Breast Cancer
      • Charlotte, North Carolina
        Levine Cancer Institute
      Aug 31, 2023

      Triple Negative Breast Cancer Trial in Guangzhou (Capecitabine, Tucidinostat)

      Recruiting
      • Triple Negative Breast Cancer
      • Guangzhou, Guangdong, China
        Sun-yat sen university cancer center
      Nov 1, 2022

      Metastatic Triple-negative Breast Cancer Trial in Wuhan (Surufatinib, Tislelizumab)

      Not yet recruiting
      • Metastatic Triple-negative Breast Cancer
      • Wuhan, Hubei, China
        Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
      Feb 27, 2023

      Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

      Not yet recruiting
      • Breast Cancer Triple Negative
      • +3 more
        • Atlanta, Georgia
          Emory University/Winship Cancer Institute
        May 18, 2023

        Triple Negative Breast Cancer Trial in Beijing (Eribulin Mesylate, Lobaplatin)

        Recruiting
        • Triple Negative Breast Cancer
        • Beijing, Beijing, China
          Cancer Hospital Chinese Academy of Medical Sciences
        Sep 15, 2022

        BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)

        Completed
        • BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
        • Barretos, SP, Brazil
          Barretos Cancer Hospital
        Dec 25, 2022

        Checkpoint Inhibitors in Triple Negative Breast

        Recruiting
        • Triple Negative Breast Cancer
        • Whole Genome Sequencing
        • +7 more
        • Barcelona, Spain
          Vall d'Hebron Institute of Oncology
        Jun 20, 2023

        Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

        Not yet recruiting
        • Triple Negative Breast Neoplasms
        • Pembrolizumab injection
        • +2 more
        • (no location specified)
        Jul 25, 2023

        Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

        Not yet recruiting
        • Breast Cancer
        • Triple Negative Breast Cancer
        • (no location specified)
        Jun 11, 2023

        TNBC - Triple-Negative Breast Cancer Trial in Brussels (Ga-PSMA PET/CT)

        Recruiting
        • TNBC - Triple-Negative Breast Cancer
        • Ga-PSMA PET/CT
        • Brussels, Belgium
          Institut Jules Bordet
        Sep 26, 2023

        Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))

        Not yet recruiting
        • Triple Negative Breast Cancer
        • +6 more
        • Implantable Microdevice (IMD)
        • Boston, Massachusetts
        • +1 more
        Mar 8, 2023

        TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

        Not yet recruiting
        • TNBC - Triple-Negative Breast Cancer
        • (no location specified)
        May 8, 2023

        Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

        Not yet recruiting
        • Triple Negative Breast Cancer
        • +2 more
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Jul 25, 2023

        TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

        Not yet recruiting
        • TNBC - Triple-Negative Breast Cancer
        • Alkaline Glucosodiene Molecules
        • (no location specified)
        Jul 14, 2023